The results of the Pfizer vaccine study on ages 12 years and under
Erika Whittome made this Official Information request to Ministry of Health
Currently waiting for a response from Ministry of Health, they must respond promptly and normally no later than (details and exceptions).
From: Erika Whittome
Dear Ministry of Health,
The Medsafe Risk Management Plan lists this study C4591007 as one of the additional pharmacovigilance activities.
The study C4591007 is "To assess the safety, tolerability, immunogenicity and efficacy of the BNT162b2 RNA-based COVID-19 vaccine candidate against COVID-19 in healthy paediatric subjects. "
(https://www.medsafe.govt.nz/COVID-19/Com... in table 3 and table 8.)
The pending completion of this study was to be 10–3-2023 according to Pfizer.
1. Would you please share the results of this study C4591007 for those aged under 12 years?
2. Please share all the information the MoH holds (or other agency) on this study C4591007 for population ages under 12 years. Please include MoH's review of this study (or other agency) as captured in meeting minutes, memos or any other correspondence.
Yours faithfully,
Erika Whittome
Things to do with this request
- Add an annotation (to help the requester or others)
- Download a zip file of all correspondence (note: this contains the same information already available above).